Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
about
Lesser-Known Molecules in Ovarian CarcinogenesisThe emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer.ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to boneActivated Leukocyte Cell Adhesion Molecule (ALCAM) in Saudi Breast Cancer Patients as Prognostic and Predictive Indicator.The effect of lifestyle intervention in obesity on the soluble form of activated leukocyte cell adhesion moleculeElevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery.The Unique Molecular and Cellular Microenvironment of Ovarian CancerA systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker.Revisiting ovarian cancer microenvironment: a friend or a foe?Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.
P2860
Q26784533-9CDBCD63-EFB1-4157-BCB9-0992E1B301C3Q33691489-80DB6DC4-B438-4C34-9CC9-F5F2F7DE7754Q34112011-2E9DAF79-234B-41FA-883A-CAA8BD17BBA1Q36089828-33E93F04-C3D4-4AF1-A2D3-010AC6AB4496Q36163154-5C4C1547-3D5D-4BED-BE04-8B0CAE0FDDEFQ37650715-583BF47C-C68A-430F-AA4E-E5A339C46D14Q37702349-AF44EF2F-1E45-494C-AD50-7672DAE5F262Q38439155-2CCA45B5-5D26-417D-AF32-C51083DAEBF7Q38470014-5F705531-43DB-4DCD-A1D2-36BB17283508Q38773416-66097D7A-76C4-4B19-AD5C-CABD78EB2EEAQ39169603-F60A69CA-90A8-42EF-B202-6D3EA4FC57B8Q39615435-0DD2F972-5C18-45B1-BBEE-37B5D1717F5EQ47773956-F408C292-3244-4BCC-9A5A-B006109AAA05Q49913406-1A74DB82-2279-4A2D-BD2C-8CD008DD293DQ52571266-138A7A7A-E299-4EDB-90FC-943EBD00C215
P2860
Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activated leukocyte cell adhes ...... s increased in type II tumors.
@en
Activated leukocyte cell adhes ...... s increased in type II tumors.
@nl
type
label
Activated leukocyte cell adhes ...... s increased in type II tumors.
@en
Activated leukocyte cell adhes ...... s increased in type II tumors.
@nl
prefLabel
Activated leukocyte cell adhes ...... s increased in type II tumors.
@en
Activated leukocyte cell adhes ...... s increased in type II tumors.
@nl
P2093
P2860
P50
P356
P1476
Activated leukocyte cell adhes ...... s increased in type II tumors.
@en
P2093
Andrea Puppo
Anna Maria Orengo
Antonella Brizzolara
Laura Emionite
Maria Grazia Centurioni
Milena Bruzzone
Paola Marroni
Silvana Canevari
P2860
P304
P356
10.1002/IJC.27948
P577
2012-12-13T00:00:00Z